| EliA GliadinDP IgG Well in the Phadia 2500EE instrument (Material Number 12410002)
EliA GliadinDP IgG is intended for the in vitro semi-quantitat…Z-2040-2023 · MST | Phadia US Inc | Recall | Jun 30, 2023FDA classification date |
| Phadia 2500EE instrument -Intended for the in vitro semi-quantitative measurement of IgG antibodies directed to gliadin in human serum or plasma …Z-2041-2023 · MST | Phadia US Inc | Recall | Jun 30, 2023FDA classification date |
| EliA dsDNA Well - Product Usage: intended for the In-Vitro quantitative measurement of IgG antibodies directed to dsDNA in human serum and plasma…Z-1107-2021 · LSW | Phadia US Inc | Recall | Feb 11, 2021FDA classification date |
| ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01).
ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of …Z-1312-2018 · DHB | Phadia US Inc | Recall | Apr 5, 2018FDA record creation date |
| ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016).
ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement …Z-1313-2018 · DHB | Phadia US Inc | Recall | Apr 5, 2018FDA record creation date |
| Phadia 1000 Instrument, Article Number 12-3800-01.Z-0387-2018 · DHB | Phadia US Inc | Recall | Jan 18, 2018FDA record creation date |
| EliA Sample Diluent, Article number, 83-1023-01Z-1253-2017 · NHX | Phadia US Inc | Recall | Feb 24, 2017FDA classification date |
| ELIA M2; IMMUNOASSAY, POSITIVE CONTROL 100, POSITIVE CONTROL 250K141375 · DBM | Phadia US, Inc. | 510(k) | Feb 13, 2015FDA decision date |
| Phadia 1000 Instrument (introduced as UniCAP 1000), Article number: 12-3800-01 (All instrument software versions since launch in 2003); Multiple …Z-0947-2015 · DHB | Phadia US Inc | Recall | Jan 12, 2015FDA classification date |
| ELIA PR3S IMMUNOASSAY, ELIA MPOS IMMUNOASSAY, ELIA GBM IMMUNOASSAY, ELIA ANCA/GBM POSITIVE CONTROL 100, ELIA ANCA/GBM POK140225 · MOB | Phadia US, Inc. | 510(k) | Oct 27, 2014FDA decision date |
| EIA SMDP IMMUNOASSAYK132631 · LKP | Phadia US, Inc. | 510(k) | Aug 29, 2014FDA decision date |
| ELIA(TM) CARDIOLIPIN IGA IMMUNOASSAYK131821 · MID | Phadia US, Inc. | 510(k) | Dec 23, 2013FDA decision date |
| AUTOMATED IN VITRO QUANTITATIVE ASSAY FOR THE MEASUREMENT OF ALLERGEN SPECIFIC IGE ANTIBODIESK122197 · DHB | Phadia US, Inc. | 510(k) | Aug 28, 2013FDA decision date |
| IMMUNOCAP ALLERGEN COMPONENTS BUNDLEK113841 · DHB | Phadia US, Inc. | 510(k) | Sep 13, 2012FDA decision date |
| PHADIA Varelisa Cardiolipin IgM
Cardiolipin autoantibody immunological test system (IgM class antibodies)Z-2285-2012 · MID | Phadia US Inc | Recall | Aug 28, 2012FDA classification date |
| ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAYK112414 · MSV | Phadia US, Inc. | 510(k) | Jun 22, 2012FDA decision date |
| ImmunoCAP Allergen Ri206, Cockroach American, Periplaneta americana
It is an analyte specific reagent and no intended use, however, it is typica…Z-1055-2012 · MVU | Phadia US Inc | Recall | Feb 17, 2012FDA classification date |
| IMMUNOCAP SPECIFIC IGE ALLERGEN BUNDLE, 12 ALLERGEN COMPONENTSK111919 · DHB | Phadia US, Inc. | 510(k) | Dec 22, 2011FDA decision date |
| RHEUMATOID FACTOR IMMUNOLOGICAL TEST SYSTEMK102673 · DHR | Phadia US, Inc. | 510(k) | Sep 30, 2011FDA decision date |
| ELIA GLIADIN DP IGA IMMUNOASSAY AND ELIA GLIADIN DP IGG IMMUNOASSAY, MODELS 14-5538-01, 14-5539-01K093459 · MST | Phadia US, Inc. | 510(k) | Aug 13, 2010FDA decision date |
| CARDIOLIPIN AUTOANTIBODY IMMUNOLOGICAL TEST SYSTEMK091845 · MID | Phadia US, Inc. | 510(k) | Jun 7, 2010FDA decision date |
| IMMUNOCAP RAPID READER, MODEL 12-3600-10K092978 · DHB | Phadia US, Inc. | 510(k) | Jan 19, 2010FDA decision date |
| ELIA RNP70 IMMUNOASSAY, ELIA SCI-70 IMMUNOASSAY AND ELIA JO-1 IMMUNOASSAY, MODELS 14-5511-01, 14-5506-01 AND 14-5507-01K083117 · LKO | Phadia US, Inc. | 510(k) | May 28, 2009FDA decision date |
| ELIA CENP IMMUNOASSAY, ELIA U1RNP IMMUNOASSAY, ELIA SM IMMUNOASSAY, ELIA RO IMMUNOASSAYK082759 · LKJ | Phadia US, Inc. | 510(k) | Apr 10, 2009FDA decision date |
| VARELISA RECOMBI ANA SCREEN, MODEL 12 596K083188 · LJM | Phadia US, Inc. | 510(k) | Mar 13, 2009FDA decision date |